DNER and diffuse large B-cell lymphoma: BET inhibitors sensitize germinal center B-like (GCB) subtype DLBCL cells to ferroptosis induction, and their combined use with ferroptosis inducers, such as RSL3, enhances their cytotoxic effect on DLBCL cells both in vitro and in vivo.